Article Details
Retrieved on: 2021-08-05 00:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Ublituximab (TG-1101) is a monoclonal antibody that targets CD20 positive B-cells, a component of the body's immune system. The drug is being ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here